Praxis Precision Medicines Inc
PRAX
Health Care
2
exclusion reasons
1 theme
Praxis Precision Medicines Inc is screened out under 2 exclusion reasons spanning 1 issue category.
This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. It is a statement of values.
Praxis Precision Medicines is a clinical-stage biopharmaceutical company whose drug development pipeline relies on animal testing. The company’s public filings document the use of *in vivo* models to evaluate its drug candidates. For example, its investigational compound elsunersen demonstrated “significant, dose-dependent reduction in seizures” and “improvement in behavioral and locomotor activity” in animal studies, which are a central component of its preclinical research and regulatory submission strategy.
This reliance on animal testing is standard for the biopharmaceutical industry but places the company within the broad exclusion category for commercial animal exploitation. The available evidence from SEC filings is limited to these procedural disclosures and does not detail the scale or specifics of the company’s animal testing operations.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company whose drug development pipeline relies on animal testing as a core component of its preclinical research. The company’s public filings explicitly state that its development process includes “preclinical laboratory tests, animal studies and formulation studies in accordance with Good Laboratory Practice.” These animal studies are conducted to assess potential toxicity and support subsequent clinical testing, a standard but required step for regulatory approval of its neurological disorder treatments. As a pharmaceutical company whose business model is predicated on bringing new drugs to market, Praxis commissions and funds animal testing, whether conducted in-house or outsourced to contract research organizations.
Research Sources
1 organization
Related Exclusions
Wondering what we do invest in?
The Naughty List
A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.
Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.
This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.
Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.